ReviewWorld journal of hepatology2019

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure.

Brianna J Shinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.